Getting your player ready...
TRENTON, N.J.. — British drugmaker GlaxoSmithKline PLC is restructuring its U.S. operations, starting with reducing its U.S. sales force by 1,000, following many of its competitors in eliminating sales jobs
TRENTON, N.J.. — British drugmaker GlaxoSmithKline PLC is restructuring its U.S. operations, starting with reducing its U.S. sales force by 1,000, following many of its competitors in eliminating sales jobs